Exosomes Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services), By Application (Cancer, CVD), By Workflow (Isolation Methods, Downstream Analysis), By End-use, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the exosomes market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for exosomes market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of exosomes market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Exosomes Market Categorization:

The exosomes market was categorized into five segments, namely product (Kits & Reagents, Instruments, Services), workflow (Isolation Methods, Downstream Analysis), application (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases), end-use (Pharmaceutical & biotechnology companies, Hospitals & diagnostics centers, Academic & research institutes), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Segment Market Methodology:

The exosomes market was segmented into product, workflow, application, end-use, and region. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The exosomes market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-four countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Exosomes market companies & financials:

The exosomes market was analyzed via companies operating in the

• FUJIFILM HOLDINGS CORPORATION - FUJIFILM Holdings Corporation is committed to introduce innovative products in healthcare and other business sectors using its imaging and information technology. Its medical business segment offers digital imaging solutions, special solutions, web-based medical imaging, computed radiography, digital radiography, digital mammography, dry imager, film & screen, endoscopy, point-of-care testing products, and ultrasound system.

• THERMO FISHER SCIENTIFIC, INC - Thermo Fisher Scientific, Inc. is a publicly held biotechnology company established after the collaboration of Fisher Scientific and Thermo Electron. In 2013, it acquired Life Technologies Corporation in a competitive bidding with Hoffman La Roche. Thermo Fisher provides products for the fields of life sciences, industrial & applied science, and clinical diagnostics. The company operates in over 50 countries.

• DANAHER CORPORATION - Danaher, through its diagnostic and life science segments, offers products and solutions for both treatments of diseases and life science research. Danaher’s diagnostics platform supplies reagents, analytical instruments, software, consumables, and services for physician’s offices, hospitals, reference laboratories, and other critical care settings. It allows disease diagnosis and monitoring to assist in treatment and therapy.

• LONZA - Lonza supplies biopharmaceuticals worldwide and offers a range of products in pharma & biotech, consumer care, bioresearch, water treatment, agro ingredients, industrial solutions, and wood protection. The company’s market is segmented into Pharma & biotech and specialty ingredients. In March 2009, the company became a part of United Nations Global Compact as a strategic initiative to enhance its business. Lonza operates in North America, Europe, Asia, France, the UK, and others.

• ILLUMINA, INC. - Illumina Inc.’s primary business includes development, manufacture, and distribution of integrated platforms and systems for sequencing. It is also involved in analysis and investigation of genomic & proteomic information, determination of biological function, and expression of a gene sequence. The company provides next-generation sequencing platforms for genotyping, sequencing, and gene expression analysis. It majorly operates in North American and European NGS market.

• QIAGEN - QIAGEN is a biotechnology company that operates in over 20 countries. Key business areas of the company include assay technologies for molecular diagnostics, pharmaceuticals, academics, and applied testing. Furthermore, molecular technologies developed by the company are being utilized by forensic technicians. The company is also involved in isolation of genetic material from biological samples. It partners with pharmaceutical companies for development of companion diagnostics.

• TAKARA BIO INC. - Takara Bio is a public company that develops services, reagents, and kits. This company operates as a member of Takara Bio Group. It holds nearly 30 patents and provides innovative solutions for gene expression analysis, signal transduction, apoptosis, and sub-cellular localization. Its product line includes products for applied products, cDNA synthesis & library construction, cell biology & epigenetics, cloning & competent cells, fluorescent proteins & reporters, genome editing, glycobiology, inducible systems, molecular biology tools, nucleic acid purification, PCR, protein expression & purification, protein interactions & profiling, real-time qPCR & reverse transcription, stem cell research, transfection & cell culture, and viral transduction.

• MILTENYI BIOTEC - Miltenyi Biotec is engaged in the development of products for biomedical research and cellular therapy. Various research areas served by this firm include immunology, stem cell research, neuroscience, cancer research, and cardiovascular research. Its portfolio for clinical applications include solutions for clinical trials, graft engineering, immunotherapy, tissue regeneration, clinical flow cytometry, GMP products, freezing products, apoptotic cell removal, and TheraSorb. Its offices and subsidiaries are located in North America, Europe, and Asia Pacific. It also operates through its distribution network in these regional markets.

• MALVERN PANALYTICAL LTD - Malvern Panalytical was formed as a result of a merger between PANalytical B.V. and Malvern Instruments Limited in January 2017. However, the company’s history dates back to 1975 by the foundation of Malvern Instruments Ltd. The company provides materials and biophysical characterization technology for better understanding of dispersed systems. It offers solutions for system that ranges from proteins & polymers in solution, particle & nanoparticle suspensions & emulsions, through to aerosols, high concentration slurries, and industrial bulk powders.

• HITACHI CHEMICAL CO., LTD. (SHOWA DENKO MATERIALS CO LTD) - Hitachi Chemical Co., Ltd. now known as - Showa Denko Materials Co Ltd, operates in the exosomes market with the help of its subsidiary Hitachi Chemical Diagnostics, Inc. The companies are a member of the Hitachi Group. Hitachi Chemical Diagnostics is committed to deliver solutions for allergy diagnostics.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Exosomes Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Exosomes Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.